IDegLira: combining efficacy, durability, and convenience?

Srikanth Bellary; Abd A Tahrani; Anthony H Barnett

doi:10.1016/S2213-8587(19)30198-6

IDegLira: combining efficacy, durability, and convenience?

Srikanth Bellary, Abd A Tahrani, Anthony H Barnett

Research output: Contribution to journal › Article › peer-review

Original language	English
Pages (from-to)	584-585
Number of pages	2
Journal	The Lancet Diabetes and Endocrinology
Volume	7
Issue number	8
DOIs	https://doi.org/10.1016/S2213-8587(19)30198-6
Publication status	Published - Aug 2019

Keywords

Diabetes Mellitus, Type 2
Drug Combinations
Humans
Insulin Glargine
Insulin, Long-Acting
Liraglutide

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/S2213-8587(19)30198-6

Cite this

@article{467cac9f7f29447e95bf03046aa2f6fa,

title = "IDegLira: combining efficacy, durability, and convenience?",

keywords = "Diabetes Mellitus, Type 2, Drug Combinations, Humans, Insulin Glargine, Insulin, Long-Acting, Liraglutide",

author = "Srikanth Bellary and Tahrani, {Abd A} and Barnett, {Anthony H}",

year = "2019",

month = aug,

doi = "10.1016/S2213-8587(19)30198-6",

language = "English",

volume = "7",

pages = "584--585",

journal = "The Lancet Diabetes and Endocrinology",

issn = "2213-8587",

publisher = "Elsevier",

number = "8",

}

TY - JOUR

T1 - IDegLira

T2 - combining efficacy, durability, and convenience?

AU - Bellary, Srikanth

AU - Tahrani, Abd A

AU - Barnett, Anthony H

PY - 2019/8

Y1 - 2019/8

KW - Diabetes Mellitus, Type 2

KW - Drug Combinations

KW - Humans

KW - Insulin Glargine

KW - Insulin, Long-Acting

KW - Liraglutide

U2 - 10.1016/S2213-8587(19)30198-6

DO - 10.1016/S2213-8587(19)30198-6

M3 - Article

C2 - 31189518

SN - 2213-8587

VL - 7

SP - 584

EP - 585

JO - The Lancet Diabetes and Endocrinology

JF - The Lancet Diabetes and Endocrinology

IS - 8

ER -